M
Marium Husain
Researcher at Ohio State University
Publications - 38
Citations - 249
Marium Husain is an academic researcher from Ohio State University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 14 publications receiving 79 citations. Previous affiliations of Marium Husain include The Ohio State University Wexner Medical Center.
Papers
More filters
Journal ArticleDOI
Acute kidney injury in patients treated with immune checkpoint inhibitors.
Shruti Gupta,Samuel A.P. Short,Meghan E. Sise,Jason Prosek,Sethu M. Madhavan,María José Soler,Marlies Ostermann,Sandra M. Herrmann,Ala Abudayyeh,Shuchi Anand,Ilya G. Glezerman,Shveta S. Motwani,Naoka Murakami,Rimda Wanchoo,David I. Ortiz-Melo,Arash Rashidi,Ben Sprangers,Ben Sprangers,Vikram Aggarwal,A. Bilal Malik,Sebastian Loew,Christopher A. Carlos,Wei-Ting Chang,Wei-Ting Chang,Pazit Beckerman,Zain Mithani,Chintan V. Shah,Amanda DeMauro Renaghan,Sophie De Seigneux,Luca Campedel,Abhijat Kitchlu,Daniel Sanghoon Shin,Sunil Rangarajan,Priya Deshpande,Gaia M. Coppock,Mark Eijgelsheim,Harish Seethapathy,Meghan Lee,Ian A. Strohbehn,Dwight H. Owen,Marium Husain,Clara García-Carro,Sheila Bermejo,Nuttha Lumlertgul,Nuttha Lumlertgul,Nina Seylanova,Nina Seylanova,Lucy Flanders,Busra Isik,Omar Mamlouk,Jamie S. Lin,Pablo Garcia,Aydin Kaghazchi,Yuriy Khanin,Sheru K Kansal,Els Wauters,Sunandana Chandra,Kai M. Schmidt-Ott,Kai M. Schmidt-Ott,Raymond K. Hsu,Maria C Tio,Suraj Sarvode Mothi,Harkarandeep Singh,Deborah Schrag,Kenar D. Jhaveri,Kerry L. Reynolds,Frank B. Cortazar,David E. Leaf +67 more
TL;DR: In this paper, a multivariable logistic regression model was used to identify predictors of ICPi-AKI and its recovery, and the effect of rechallenge versus no re-challenge on survival was estimated.
Journal ArticleDOI
Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers.
Mingjia Li,Daniel Spakowicz,Jarred Burkart,Sandip H. Patel,Marium Husain,Kai He,Erin M. Bertino,Peter G. Shields,David P. Carbone,Claire F. Verschraegen,Carolyn J Presley,Gregory A. Otterson,Kari Kendra,Dwight H. Owen +13 more
TL;DR: Patients who had moderate decrease in NLR during treatment with ICI were found to have the longest survival, whereas a significant decrease or increase inNLR was associated with shorter survival, the first study to demonstrate a non-linear change in NLr over time that correlates with survival.
Journal ArticleDOI
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications
Daniel Spakowicz,Rebecca Hoyd,Mitchell Muniak,Marium Husain,James S. Bassett,Lei Wang,Gabriel Tinoco,Sandip H. Patel,Jarred Burkart,Abdul Miah,Mingjia Li,Andrew Johns,Madison Grogan,David P. Carbone,Claire F. Verschraegen,Kari Kendra,Gregory A. Otterson,Lang Li,Carolyn J Presley,Dwight H. Owen +19 more
TL;DR: The timing and strength of the correlations with antibiotics and corticosteroids after controlling for confounding factors are consistent with the microbiome involvement with the response to ICIs across several cancers.
Journal ArticleDOI
An overview of the unique challenges facing African-American breast cancer survivors.
Marium Husain,Timiya S. Nolan,Kevin Chu Foy,Raquel E. Reinbolt,Cassandra Grenade,Maryam B. Lustberg +5 more
TL;DR: This review surveyed current knowledge of health disparities that exist in the acute survivorship period (immediately following diagnosis and treatment) and their contributors for African-American breast cancer survivors (AA-BCS).
Journal ArticleDOI
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer.
Andrew Johns,Lai Wei,Madison Grogan,Rebecca Hoyd,John F.P. Bridges,Sandipkumar H. Patel,Mingjia Li,Marium Husain,Kari Kendra,Gregory A. Otterson,Jarred Burkart,Ashley Elizabeth Rosko,Barbara L. Andersen,David P. Carbone,Dwight H. Owen,Daniel Spakowicz,Carolyn J Presley +16 more
TL;DR: In this paper, the relationship between immune-related adverse events (irAEs) and overall survival (OS) among older adults [age ≥ 70 years (y)] remains unknown.